ORIFARM GROUP A/S

ORIFARM GROUP A/S (CVR number: 27347282K) is a company from ODENSE. The company reported a net sales of 1567.7 mEUR in 2023, demonstrating a growth of 3.6 % compared to the previous year. The operating profit percentage was at 4.8 % (EBIT: 76 mEUR), while net earnings were 22.4 mEUR. The profitability of the company measured by Return on Assets (ROA) was 6.9 %, which can be considered decent but Return on Equity (ROE) was 11.4 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 16.9 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. ORIFARM GROUP A/S's liquidity measured by quick ratio was 0.8 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.